CLPT logo

CLPT

ClearPoint Neuro, Inc.

$13.86
+$0.62(+4.70%)
38
Overall
40
Value
18
Tech
57
Quality
Market Cap
$409.01M
Volume
607.13K
52W Range
$9.76 - $30.10
Target Price
$29.00

Company Overview

Mkt Cap$409.01MPrice$13.86
Volume607.13KChange+4.70%
P/E Ratio-21.6Open$13.24
Revenue$31.4MPrev Close$13.24
Net Income$-18.9M52W Range$9.76 - $30.10
Div YieldN/ATarget$29.00
Overall38Value40
Quality57Technical18

No chart data available

About ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
ABCD
1SymbolPriceChangeVol
2CLPT$13.86+4.7%607.13K
3
4
5
6

Get ClearPoint Neuro, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.